DZ2383A1 - Process for the crystallization of a tetrahydropyridine derivative and crystalline forms thus obtained - Google Patents

Process for the crystallization of a tetrahydropyridine derivative and crystalline forms thus obtained

Info

Publication number
DZ2383A1
DZ2383A1 DZ970233A DZ970233A DZ2383A1 DZ 2383 A1 DZ2383 A1 DZ 2383A1 DZ 970233 A DZ970233 A DZ 970233A DZ 970233 A DZ970233 A DZ 970233A DZ 2383 A1 DZ2383 A1 DZ 2383A1
Authority
DZ
Algeria
Prior art keywords
crystallization
crystalline forms
tetrahydropyridine derivative
tetrahydropyridine
derivative
Prior art date
Application number
DZ970233A
Other languages
French (fr)
Inventor
Antoine Caron
Bruno Franc
Olivier Monnier
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of DZ2383A1 publication Critical patent/DZ2383A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Nutrition Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DZ970233A 1996-12-23 1997-12-22 Process for the crystallization of a tetrahydropyridine derivative and crystalline forms thus obtained DZ2383A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9615904A FR2757543B1 (en) 1996-12-23 1996-12-23 PROCESS FOR THE CRYSTALLIZATION OF A TETRAHYDROPYRIDINE DERIVATIVE AND CRYSTALLINE FORMS THUS OBTAINED

Publications (1)

Publication Number Publication Date
DZ2383A1 true DZ2383A1 (en) 2002-12-28

Family

ID=9499043

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ970233A DZ2383A1 (en) 1996-12-23 1997-12-22 Process for the crystallization of a tetrahydropyridine derivative and crystalline forms thus obtained

Country Status (39)

Country Link
EP (1) EP0950050B1 (en)
JP (2) JP4499188B2 (en)
KR (1) KR100586670B1 (en)
CN (1) CN1129580C (en)
AR (1) AR009672A1 (en)
AT (1) ATE307802T1 (en)
AU (1) AU736697B2 (en)
BR (1) BR9714081A (en)
CA (1) CA2275596C (en)
CO (1) CO5070688A1 (en)
CZ (1) CZ296689B6 (en)
DE (1) DE69734460T2 (en)
DK (1) DK0950050T3 (en)
DZ (1) DZ2383A1 (en)
EE (1) EE04188B1 (en)
EG (1) EG21567A (en)
ES (1) ES2251038T3 (en)
FR (1) FR2757543B1 (en)
HK (1) HK1024002A1 (en)
HR (1) HRP970699B1 (en)
HU (1) HU227425B1 (en)
IL (1) IL129938A (en)
IN (1) IN186976B (en)
IS (1) IS2357B (en)
MY (1) MY118015A (en)
NO (1) NO312364B1 (en)
NZ (1) NZ336130A (en)
PL (1) PL190494B1 (en)
RS (1) RS49882B (en)
RU (1) RU2192416C2 (en)
SA (1) SA98180971B1 (en)
SI (1) SI0950050T1 (en)
SK (1) SK285088B6 (en)
TR (1) TR199901363T2 (en)
TW (1) TW518322B (en)
UA (1) UA60324C2 (en)
UY (1) UY24825A1 (en)
WO (1) WO1998028271A1 (en)
ZA (1) ZA9711576B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757543B1 (en) * 1996-12-23 1999-04-02 Sanofi Sa PROCESS FOR THE CRYSTALLIZATION OF A TETRAHYDROPYRIDINE DERIVATIVE AND CRYSTALLINE FORMS THUS OBTAINED
FR2782082B3 (en) * 1998-08-05 2000-09-22 Sanofi Sa CRYSTALLINE FORMS OF (R) - (+) - N - [[3- [1-BENZOYL-3- (3,4- DICHLOROPHENYL) PIPERIDIN-3-YL] PROP-1-YL] -4-PHENYLPIPERIDIN-4 - YL] -N-METHYLACETAMIDE (OSANETANT) AND PROCESS FOR THE PREPARATION OF SAID COMPOUND
WO2011111856A1 (en) 2010-03-12 2011-09-15 株式会社日本触媒 Method for manufacturing a water-absorbing resin
EP2643294B1 (en) * 2011-04-15 2016-08-24 Emcure Pharmaceuticals Limited An improved rilpivirine process

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531707A1 (en) * 1982-08-16 1984-02-17 Midy Spa SUBSTITUTED TRIFLUOROMETHYLPHENYLTETRAHYDROPYRIDINES WITH ANOREXIGENIC ACTIVITY, A PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS
FR2757543B1 (en) * 1996-12-23 1999-04-02 Sanofi Sa PROCESS FOR THE CRYSTALLIZATION OF A TETRAHYDROPYRIDINE DERIVATIVE AND CRYSTALLINE FORMS THUS OBTAINED

Also Published As

Publication number Publication date
WO1998028271A1 (en) 1998-07-02
EG21567A (en) 2001-12-31
CN1129580C (en) 2003-12-03
MY118015A (en) 2004-08-30
UY24825A1 (en) 1998-04-21
SK285088B6 (en) 2006-06-01
PL334256A1 (en) 2000-02-14
IN186976B (en) 2001-12-22
NZ336130A (en) 2001-01-26
HRP970699A2 (en) 1998-10-31
HK1024002A1 (en) 2000-09-29
JP4499188B2 (en) 2010-07-07
RS49882B (en) 2008-08-07
NO993076D0 (en) 1999-06-22
EE9900264A (en) 2000-02-15
AU736697B2 (en) 2001-08-02
NO312364B1 (en) 2002-04-29
UA60324C2 (en) 2003-10-15
IS5076A (en) 1999-06-10
ES2251038T3 (en) 2006-04-16
IL129938A0 (en) 2000-02-29
EP0950050B1 (en) 2005-10-26
KR20000069504A (en) 2000-11-25
KR100586670B1 (en) 2006-06-07
TR199901363T2 (en) 1999-08-23
HUP0001387A2 (en) 2000-09-28
JP2009197022A (en) 2009-09-03
DE69734460D1 (en) 2005-12-01
BR9714081A (en) 2000-05-09
JP2001507012A (en) 2001-05-29
SK82899A3 (en) 1999-12-10
EE04188B1 (en) 2003-12-15
PL190494B1 (en) 2005-12-30
CA2275596C (en) 2005-10-11
IL129938A (en) 2004-06-20
TW518322B (en) 2003-01-21
EP0950050A1 (en) 1999-10-20
SA98180971B1 (en) 2006-09-13
FR2757543A1 (en) 1998-06-26
IS2357B (en) 2008-04-15
DE69734460T2 (en) 2006-07-06
YU28999A (en) 2003-01-31
CA2275596A1 (en) 1998-07-02
RU2192416C2 (en) 2002-11-10
CZ296689B6 (en) 2006-05-17
AU5668498A (en) 1998-07-17
ZA9711576B (en) 1998-06-25
AR009672A1 (en) 2000-04-26
CO5070688A1 (en) 2001-08-28
CZ229299A3 (en) 1999-09-15
DK0950050T3 (en) 2006-01-23
SI0950050T1 (en) 2006-04-30
HUP0001387A3 (en) 2002-03-28
ATE307802T1 (en) 2005-11-15
FR2757543B1 (en) 1999-04-02
NO993076L (en) 1999-06-22
CN1241180A (en) 2000-01-12
HRP970699B1 (en) 2007-03-31
HU227425B1 (en) 2011-05-30

Similar Documents

Publication Publication Date Title
FR2744010B1 (en) PROCESS FOR THE MANUFACTURE OF BONE IMPLANTS
FR2708601B1 (en) Iopamidol crystallization process.
DZ2032A1 (en) A process for the preparation of lercanidipine hydrochloride.
MA23179A1 (en) PROCESS FOR THE PREPARATION OF A CRYSTALLINE MONOHYDRATE OF A SPIROSTANYLGLYCOSIDE
FR2764883B1 (en) PROCESS FOR THE MANUFACTURE OF HYDROFLUOROALCANES
FR2743808B1 (en) PROCESS FOR THE PREPARATION OF ALKYL CHLORIDES
DZ2383A1 (en) Process for the crystallization of a tetrahydropyridine derivative and crystalline forms thus obtained
FR2754816B1 (en) PROCESS FOR THE PURIFICATION OF HYDROGENOCHLOROFLUOROETHANES
MA24534A1 (en) PROCESS FOR THE PRODUCTION OF IRONES
DZ3074A1 (en) Crystalline forms of (R) - (+) - N-Ä3-Ä1 berizoyl-3- (3,4-dichlorophenyl) piperidin-3YLÜpropyl-1-YLÜ-4-phenylpiperidin-4-YLÜ-N-methylacetamide (osanetant) and process for their preparation.
FR2633290B1 (en) PROCESS FOR THE MANUFACTURE OF IODOALCYNYL CARBAMATES
MA23081A1 (en) PROCESS FOR THE PREPARATION OF INDOLONE DERIVATIVES
FR2755238B1 (en) CHARACTERIZATION METHOD OF A PHOTOREPECTOR
FR2644161B1 (en) PROCESS FOR THE PREPARATION OF N-ARYLSUBSTITUTED AMIDES
MA22200A1 (en) PROCESS FOR THE PREPARATION OF AMINODIOL DERIVATIVES
FR2729387B1 (en) PROCESS FOR THE MANUFACTURE OF HYDROXY-ALCOXY-BENZOPHENONES
NO308471B1 (en) Processes for the preparation of loracarbef monohydrate and crystalline anhydrate form of loracarbef
FR2615185B1 (en) PROCESS FOR THE PREPARATION OF TRIFLUOROMETHYLTOLUENE FROM HALOMETHYLBENZOTRIFLUORIDE
FR2732154B1 (en) PROCESS FOR THE MANUFACTURE OF INSULATORS
FR2757510B1 (en) MICROPARTICLE FORM OF A TETRAHYDROPYRIDINE DERIVATIVE
MA23986A1 (en) PROCESS FOR THE PREPARATION OF CRYSTALLINE TRISODE PHOSPHATE HYDRATES
MA24258A1 (en) PROCESS FOR MONOACYLATION OF HYDOXYTAXANES
FR2723293B1 (en) PROCESS FOR THE PRODUCTION OF A TOURON-TYPE CONFECTIONERY
FR2742431B1 (en) PROCESS FOR THE PREPARATION OF CONSTRUCTION AGGREGATES FROM MACHEFERS
FR2742450B1 (en) PROCESS FOR THE PRODUCTION OF HYPOCHLORITE